title: Activity of phospholipase C and release of prostaglandin F2 alpha by endometrial tissue from ovariectomized ewes receiving progesterone and estradiol.
abstract: Progesterone and estradiol interact to regulate secretion of prostaglandin (PG) F2 alpha from the ovine endometrium in response to oxytocin. Two experiments were conducted to determine if these effects were due to changes in activity of phospholipase C or in the second messenger responsive pathways that regulate production of PGF2 alpha. In both experiments, ovariectomized ewes were assigned to one of four treatment groups (control, estradiol, progesterone, progesterone and estradiol). Steroids were administered, in vivo, to mimic the changes that occur during the estrous cycle. On Day 16 of steroid treatment, endometrial tissue was collected and incubated, in vitro, to measure activity of phospholipase C and release of PGF2 alpha. Treatment with progesterone, in vivo, enhanced basal and oxytocin-induced activity of phospholipase C and release of PGF2 alpha, in vitro. Estradiol suppressed oxytocin-induced activity of phospholipase C, both in the presence and absence of progesterone. In contrast to its effects on phospholipase C, estradiol inhibited basal and oxytocin-induced release of PGF2 alpha when administered alone, but not when administered with progesterone. Steroids had similar effects on the release of PGF2 alpha induced by phorbol 12-myristate 13-acetate and A23187. It was concluded that progesterone and estradiol regulate endometrial release of PGF2 alpha by affecting both the activity of phospholipase C and its associated second messenger responsive pathways that may regulate production of PGF2 alpha.
authors.affiliation: Department of Animal Sciences, University of Kentucky, Lexington 40546-0215.
authors.forename: R E
authors.initials: RE
authors.lastname: Raw
authors.forename: W J
authors.initials: WJ
authors.lastname: Silvia
mesh_terms: D000818:Animals; D015237:Dinoprost / Q000378:metabolism*; D004717:Endometrium / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D010052:Ovariectomy; D011374:Progesterone / Q000494:pharmacology; D015290:Second Messenger Systems / Q000187:drug effects; D012756:Sheep; D010738:Type C Phospholipases / Q000378:metabolism*
chemical_list: D011374:Progesterone; D004958:Estradiol; D015237:Dinoprost; D010738:Type C Phospholipases